ChristopherRobertPalmaMDScM(He/Him)
Rheumatology • Canandaigua, NYLupus & Related, Rheumatoid Arthritis & Related, Vasculitis
Assistant Professor of Medicine
Dr. Palma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
335 Parrish St
Canandaigua, NY 14424Phone+1 585-486-0901Fax+1 585-340-5399
Education & Training
University of RochesterFellowship, Rheumatology, 2014 - 2016- University of RochesterResidency, Internal Medicine, 2011 - 2014
University of Rochester School of Medicine and DentistryClass of 2011
Johns Hopkins Bloomberg School of Public HealthScM, Microbiology and Immunology, 2005 - 2007- Johns Hopkins UniversityScM, 2005 - 2007
- Yale UniversityBS, Biology, 2001 - 2005
- Yale UniversityB.S., 2001 - 2005
Certifications & Licensure
NY State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology, 2016
- Fellow American Board of Internal Medicine, 2014
- Fellow American College of Medicine, 2014
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA Start of enrollment: 2018 Oct 15
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders Start of enrollment: 2021 Aug 13
- Immune Modulators for Treating COVID-19 Start of enrollment: 2020 Oct 15
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsRandomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.Lindsay Rein, Karel Calero, Ronak Shah, Charles Ojielo, Kristin M Hudock
Critical Care Medicine. 2022-12-01 - 9 citationsInfliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, Matthew W McCarthy, Emily R Ko
Medrxiv. 2022-09-26 - 7 citationsAbatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, Anne M Lachiewicz, Martin Maillo
Medrxiv. 2022-09-26
Journal Articles
- Characterization of di-, tri-, and tetranucleotide microsatellite markers with perfect repeats for Trypanosoma brucei and related speciesBalmer O; Palma C; Macleod A; Caccone A, Molecular Ecology Notes, 1/1/2006
Professional Memberships
- Member
- Fellow
External Links
- profilehttps://www.urmc.rochester.edu/medicine/allergy/faculty/christopher-palma.aspx
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
